Sonoma Pharmaceuticals, Inc.
SNOA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001367083
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $136.3K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Sonoma Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 16 | 20 | +4 |
| Shares | 164.3K | 435.0K | +270.7K (+164.8%) |
| Value | $27.3K | $91.7K | +$64.4K (+235.9%) |
New holders (7)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 195,157 | $41.4K | 0.00% |
| Jane Street Group, LLC | 45,295 | $9.61K | 0.00% |
| HRT Financial LP | 21,519 | $4.00K | 0.00% |
| Qube Research & Technologies Ltd | 3,400 | $722 | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $42 | 0.00% |
| Painted Porch Advisors LLC | 5 | $1 | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 46,052 | $7.66K |
| Millennium Management LLC | 13,016 | $2.17K |
| CWM, LLC | 6 | $0 |